The opinion in support of the decision being entered today was not written for publication and is not binding precedent of the Board. UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE BOARD OF PATENT APPEALS AND INTERFERENCES __________ Ex parte NANA K. AYISI __________ Appeal No. 2006-1608 Application No. 09/978,593 __________ ON BRIEF __________ Before SCHEINER, MILLS, and GREEN, Administrative Patent Judges. GREEN, Administrative Patent Judge. DECISION ON APPEAL This is a decision on appeal under 35 U.S.C. § 134 from the examiner’s final rejection of claims 20, 22, 31 and 32, which read as follows: 20. The method according to claim 31, wherein the virus is human immunodeficiency virus (HIV), herpes simplex virus (HSV), human cytomegalovirus (HCMV), poliovirus (PV), measles virus (MV) or yellow fever virus (YMV). 22. The method according to claim 20, wherein the virus is HIV-1, HCMV, HSV-1 or HSV-2. 31. A method comprising: contacting a virus-infected cell with an extract from Ocimum gratissimum in an amount effective to inhibit cytopathic effects of the virus in the cell. 32. The method according to claim 20, wherein the virus is HIV.Page: 1 2 3 4 5 6 7 8 9 NextLast modified: November 3, 2007